Mackenzie Financial’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,456	Closed	-$261K	–	1439
2021 Q4	$261K	Sell	4,456 -240	-5%	-$14.1K	﹤0.01%	1211
2021 Q3	$278K	Buy	4,696 +1,914	+69%	+$113K	﹤0.01%	1167
2021 Q2	$241K	Buy	+2,782	New	+$241K	﹤0.01%	1111